Oriel — AI & technology worth noticing, every day.

Early progress on accelerating drug development with Claude

Web page · https://anthropic.com/research/early-progress-drug-development

First seen by Oriel on .

AI summary

Anthropic reports early partnerships and internal programs using Claude across drug discovery, manufacturing, regulatory work, and clinical planning, with promising preclinical results and plans to scale.

  • Generate Biomedicines used Claude Code to design a CAR T-cell instruction sequence about 70% shorter, producing roughly 10 times more receptors and improved tumor-cell killing.
  • Divergence Labs generated roughly 35,000 antibody designs in about a month; early testing found 23 binding or IgE-displacing hits, including three outperforming standard medication.
  • BigHat tested about 1,010 molecule variants in 10 weeks, achieving tighter binding, improved heat stability, and over 100-fold slower clumping in selected leads.
  • Enveda connected manufacturing documents to Claude, which found all 11 human-identified issues plus seven others and reduced review time by 89%.
  • The work remains mostly preclinical, while Anthropic expands Claude’s use through Claude Science, credits, verification programs, and additional research partnerships.

#drug discovery #claude #biotechnology #clinical trials

Generated by gpt-5.6-sol. Check the original for details.

Metric trends

Last 30 days · Up to 120 recorded samples per source and metric, with reposts kept separate · First and latest retained

Points

Score reported by the source.

  • Hacker News: 328, latest observation ; +311 over observed period since

Comments

Comment count reported by the source.

  • Hacker News: 338, latest observation ; +337 over observed period since

Aliases

SourceExternal IDURL
Hacker News50265609https://www.anthropic.com/research/early-progress-drug-development Read discussion